Community-Wide Isoniazid Preventive Therapy Drives Drug-Resistant Tuberculosis: A Model-Based Analysis

Initial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic Review and Meta-analysis

(2013) Woojin Lew et al.   ANNALS OF INTERNAL MEDICINE

Approval of Novel TB Drug Celebrated--With Restraint

(2013) J. Cohen   SCIENCE

Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium tuberculosis

(2012) Jason R. Andrews et al.   CLINICAL INFECTIOUS DISEASES

Mixed-Strain Mycobacterium tuberculosis Infections and the Implications for Tuberculosis Treatment and Control

(2012) T. Cohen et al.   CLINICAL MICROBIOLOGY REVIEWS

Undiagnosed Tuberculosis Among HIV Clinic Attendees

(2012) Tendesayi Kufa et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

A mouse model of tuberculosis reinfection

(2012) Marcela Henao-Tamayo et al.   TUBERCULOSIS

Epidemiologic Inference From the Distribution of Tuberculosis Cases in Households in Lima, Peru

(2011) E. Brooks-Pollock et al.   JOURNAL OF INFECTIOUS DISEASES

Models to understand the population-level impact of mixed strain M. tuberculosis infections

(2011) Rinat Sergeev et al.   JOURNAL OF THEORETICAL BIOLOGY

6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial

(2011) Taraz Samandari et al.   LANCET

Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection

(2011) Christopher B Ford et al.   NATURE GENETICS

Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009

(2011) Helen E. Jenkins et al.   PLoS One

Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies

(2011) Haileyesus Getahun et al.   PLOS MEDICINE

Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting

(2010) Clare L van Halsema et al.   AIDS

Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening

(2010) Gavin J Churchyard et al.   AIDS

Intensive Tuberculosis Screening for HIV‐Infected Patients Starting Antiretroviral Therapy in Durban, South Africa

(2010) Ingrid V. Bassett et al.   CLINICAL INFECTIOUS DISEASES

Opportunities afforded by new drugs for tuberculosis

(2010) Gavin J Churchyard et al.   LANCET INFECTIOUS DISEASES

A replication clock for Mycobacterium tuberculosis

(2009) Wendy P Gill et al.   NATURE MEDICINE

Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment

(2009) W. E. Harrington et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis

(2009) Dick Menzies et al.   PLOS MEDICINE

Trafficking of SuperinfectingMycobacteriumOrganisms into Established Granulomas Occurs in Mammals and Is Independent of the Erp and ESX‐1 Mycobacterial Virulence Loci

(2008) Christine L. Cosma et al.   JOURNAL OF INFECTIOUS DISEASES